Dr.
Cotman is Director of the Institute for Brain Aging and Dementia and a Professor
in the Departments of Neurology and Psychobiology at the University of California,
Irvine.
Research Interests:
Synaptic plasticity and functional recovery after injury and disease in the
mature and aged central nervous system.
He earned his Bachelor of Arts degree in 1962 from Wooster College, majoring
in chemistry. He received his master.s degree in analytical chemistry from Wesleyan
University in 1964 and continued his training at Indiana University where his
dissertation on the isolation and characterization of synaptic membrane proteins
earned him his Doctorate in 1968. Thus, Dr. Cotman's early background was in
the field of analytical chemistry before he received special training in the
chemistry of the nervous system.
A statement from the Director:
Our goal is to determine the nature of natural healing processes in the nervous
system and to develop new therapeutic interventions. In most organs, cells can
divide and thus replace those lost due to injury or disease. In contrast, most
nerve cells do not divide. Therefore, for many years, the brain and spinal cord
were believed to have little if any ability to repair damaged circuits. This
belief, however, conflicted with clinical experience showing that patients at
least partially recover from minor injuries, i.e., trauma, stroke, and short-term
degenerative diseases. Our research centers on studying the mechanisms by which
recovery may be achieved and on facilitating such recovery, e.g., by enhancing
the growth and compensatory reorganization of remaining connections, and injecting
factors which facilitate the repair of damaged circuits.
Our work and that of others has shown that following the loss of neurons in
the hippocampus of rodents, the remaining fibers from healthy nerve cells grow
collateral sprouts and make new synapses to replace those lost, a process known
as reactive synaptogenesis (the formation of new nerve connections). Reactive
synaptogenesis may facilitate functional recovery in cases involving partial
cell loss within a defined neuronal population by stabilizing the circuits,
counteracting further cell loss, and preventing potentially greater functional
decline. It is the natural repair process for cell loss in the central nervous
system.
Research
over the past ten years on sprouting and reactive synaptogenesis using the rodent
hippocampal formation as a model system has progressed to the point where it
is possible to predict which responses might occur in humans. In Alzheimer.s
disease, neurons are lost slowly over time as the brain degenerates. Data from
our lab and others across the country indicate that a selective robust sprouting
reaction occurs in the damaged hippocampal pathways within the brain of Alzheimer.s
patients. In essence, such actions rebuild the circuits to defend the brain
from the loss of its neurons.
Our main goal is to study the molecular mechanisms underlying reactive growth
in the brain in order to develop new therapies along the brain.s natural lines
of defense. It now appears that maintenance and plasticity depend on rapid signaling
via conventional neurotransmitters and long-term signaling via neurotrophic
factors (molecules which enhance cell growth or survival). Many of the transmitters
in the reactive pathways are excitatory amino acids such as glutamate and aspartate.
Current work centers on the study of receptors in postmortem brain tissue from
patients with Alzheimer.s disease. Other current work involves molecular analysis
of the regulation of neurotrophic factors and the processing and properties
of B-amyloid, a protein that accumulates in Alzheimer.s disease. What is the
precise nature of the growth factors for certain types of cells, and what controls
their production?
We are also pursuing parallel clinical studies on dementia patients in collaboration
with various clinicians at the UCI College of Medicine. We are using new imaging
methods [e.g., magnetic resonance imaging (MRI) and magnetic resonance spectroscopy
(MRS)] to examine the functions of the brain regions that demonstrate plasticity
in Alzheimer.s patients. We are conducting parallel animal studies to test the
behavioral functions of the same circuits.
It is our conviction that one of the next major areas in the neurosciences
is that of clinical psychobiology. We have an active program within the laboratory,
within the Department of Psychobiology, Neurology, and among other UCI departments
toward this end.
|